JMIEX Performance — JPMorgan Emerging Markets Equity Fund, Class L
Data updated: 2026-09-28
JMIEX returned +23.80% year to date and +46.52% over one year to Jul 2026. Annualised returns are +20.47% over 3 years and +6.15% over 5 years. The fund beat its Emerging Markets Equity category average: $100 invested three years ago grew to $175, against $164 for the category, and to $147 over one year, against $134. Volatility over the past three years was 17.32% a year. In the 12 months to Jul 2026 the fund lost a net $580.0M, and assets reached $10.84B.
JMIEX Growth of $100
What $100 invested in JPMorgan Emerging Markets Equity Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Emerging Markets Equity category average over the same months.
| Period | JMIEX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $147 | $134 |
| 3 years (Aug 2023 – Jul 2026) | $175 | $164 |
| 5 years (Aug 2021 – Jul 2026) | $135 | $143 |
| Since data start (Aug 2019 – Jul 2026) | $190 | $188 |
JMIEX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +23.80% |
| 1 year | +46.52% |
| 3 years (annualised) | +20.47% |
| 5 years (annualised) | +6.15% |
JMIEX Annual Returns
Calendar-year total returns of JPMorgan Emerging Markets Equity Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +23.80% |
| 2025 | +40.24% |
| 2024 | +3.48% |
| 2023 | +7.35% |
| 2022 | −25.68% |
| 2021 | −10.23% |
| 2020 | +34.88% |
| 2019 (Aug–Dec) | +9.44% |
JMIEX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +10.2% | +3.7% | −8.9% | +14.9% | +8.3% | +2.5% | −6.8% | — | — | — | — | — |
| 2025 | +3.1% | −0.5% | +1.2% | +0.6% | +5.7% | +6.4% | +0.9% | +3.5% | +8.7% | +4.0% | −1.8% | +3.0% |
| 2024 | −4.4% | +4.6% | +2.5% | −1.5% | +1.7% | +2.9% | −1.0% | +1.4% | +4.0% | −3.2% | −2.6% | −0.6% |
| 2023 | +10.1% | −6.4% | +1.9% | −1.4% | −1.8% | +4.6% | +3.6% | −6.8% | −3.7% | −2.7% | +7.5% | +3.7% |
| 2022 | −4.9% | −7.5% | −4.4% | −6.8% | +0.9% | −4.7% | +1.1% | −1.3% | −11.0% | −3.0% | +17.6% | −2.6% |
| 2021 | +2.7% | −1.1% | −3.8% | +2.3% | +1.8% | +1.5% | −7.5% | +3.8% | −4.7% | +0.9% | −5.2% | −0.6% |
| 2020 | −3.3% | −2.9% | −17.0% | +8.5% | +4.6% | +9.7% | +9.2% | +6.2% | −1.6% | +3.9% | +8.2% | +8.4% |
| 2019 | — | — | — | — | — | — | — | −3.0% | +1.5% | +4.5% | +0.4% | +5.9% |
JMIEX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 17.32%
- 3-year Sharpe ratio: 0.92 (vs 4.5% risk-free rate)
- Best month: +14.88% (Apr 2026)
- Worst month: −8.90% (Mar 2026)
JMIEX Fund Flows
Monthly money in and out of JPMorgan Emerging Markets Equity Fund, from SEC Form N-PORT.
- 12-month net flow: −$580.0M
- 12-month gross sales (incl. reinvestments): $2.7B
- Sales ÷ redemptions: 0.82×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $177.3M | $239.6M | −$62.3M |
| Jun 2026 | $162.7M | $347.8M | −$185.1M |
| May 2026 | $154.1M | $392.3M | −$238.2M |
| Apr 2026 | $186.6M | $319.2M | −$132.6M |
| Mar 2026 | $158.9M | $252.7M | −$93.8M |
| Feb 2026 | $167.3M | $257.1M | −$89.8M |
| Jan 2026 | $175.9M | $327.7M | −$151.8M |
| Dec 2025 | $262.6M | $274.6M | −$12.0M |
| Nov 2025 | $381.4M | $202.6M | $178.8M |
| Oct 2025 | $120.2M | $227.3M | −$107.2M |
| Sep 2025 | $119.6M | $191.7M | −$72.2M |
| Aug 2025 | $600.8M | $214.8M | $386.1M |
JMIEX Assets Under Management
Net assets of JPMorgan Emerging Markets Equity Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $10.84B |
| 2026-04-30 | $10.94B |
| 2026-01-31 | $10.38B |
| 2025-10-31 | $9.42B |
| 2025-07-31 | $7.83B |
| 2025-04-30 | $6.26B |
| 2025-01-31 | $6.60B |
| 2024-10-31 | $6.98B |
| 2024-07-31 | $7.00B |
| 2024-04-30 | $7.12B |
| 2024-01-31 | $7.22B |
| 2023-10-31 | $7.09B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.